(MENAFN- GlobeNewsWire - Nasdaq) Boost ROI via automated AI annotation, cloud infrastructure, regional data centers, scalable multi-omics services, high-quality curation and strategic acquisitions.Dublin, Nov. 09, 2026 (GLOBE NEWSWIRE) -- "Genome Annotation Services Market Report 2026" has been added to ResearchAndMarkets.com's offering.
The global genome annotation services market is experiencing rapid growth as pharmaceutical companies, biotechnology organizations, clinical laboratories, and research institutions increase their use of genomic data. The market is projected to grow from $1.44 billion in 2025 to $1.63 billion in 2026, representing a compound annual growth rate (CAGR) of 13.6%.
Growth during the historical period has been supported by the expansion of genome sequencing projects, greater availability of next-generation sequencing data, increased academic genomics research, wider use of bioinformatics in drug discovery, and continued development of public genomic databases. Together, these factors have increased demand for accurate, scalable, and consistent genome annotation services.
The genome annotation services market is forecast to reach $2.75 billion by 2030, expanding at a CAGR of 13.9%. Key growth drivers include rising demand for personalized medicine research, increased adoption of artificial intelligence-powered bioinformatics platforms, expansion of precision agriculture genomics, growing investment in genomics startups, and stronger integration of clinical genomics workflows.
Prominent genome annotation market trends include the increasing use of automated gene annotation pipelines, adoption of AI-based functional annotation tools, demand for comparative genome analysis, expansion of multi-omics annotation services, and greater emphasis on high-quality manual curation. Service providers are combining automation with expert review to improve annotation accuracy while processing increasingly large and complex genomic datasets.
Demand for personalized medicine is expected to remain a major market catalyst. The rising prevalence of chronic, rare, and complex diseases is encouraging healthcare organizations to pursue treatments informed by individual genetic characteristics, disease susceptibility, and predicted drug response. Genome annotation services support this approach by converting raw sequence data into clinically actionable information that can guide diagnosis, treatment selection, and therapeutic development.
Evidence of this shift can be seen in the growing number of personalized therapies receiving regulatory approval. According to the Personalized Medicine Coalition, the U.S. Food and Drug Administration approved 16 new personalized treatments for patients with rare diseases in 2023, compared with six in 2022. The 2023 approvals also included seven cancer therapies and three treatments for other diseases and conditions.
Innovation in prokaryotic genome annotation is also advancing the market. Organizations are developing standardized in-house pipelines that combine automated gene prediction and functional annotation capabilities. These systems are designed to deliver consistent results across extensive microbial genome collections while improving data quality, comparability, and scalability.
In July 2023, the European Molecular Biology Laboratory's European Bioinformatics Institute introduced a comprehensive annotation update for genomes hosted in Ensembl Bacteria. The initiative replaced heterogeneous submitter-provided annotations with a standardized in-house prokaryotic annotation pipeline. It delivered consistent gene prediction, functional annotation, and systematic gene identifiers across tens of thousands of bacterial and archaeal genomes, improving usability for comparative genomics and microbiome research.
Strategic acquisitions are further reshaping the competitive environment. In September 2025, France-based AI-driven genomic analysis provider SeqOne acquired Congenica for an undisclosed amount. The transaction combined SeqOne's AI-powered genomic analysis platform with Congenica's clinical interpretation and decision-support capabilities. The acquisition is intended to strengthen technological capacity, accelerate personalized medicine applications, expand international reach, and support more comprehensive genome annotation and interpretation services.
The genome annotation services market covers structural annotation, functional annotation, comparative annotation, variant annotation, pathway analysis, manual curation, annotation quality assessment, database integration, and customized bioinformatics analysis. Major applications include drug discovery, personalized medicine, agriculture, clinical genomics, and biotechnology. Key end users include pharmaceutical and biotechnology companies, academic and research institutions, and clinical laboratories.
Tariffs are influencing the market by raising the cost of imported high-performance computing hardware, specialized servers, data storage systems, and other bioinformatics infrastructure. Research institutions and biotechnology companies in North America and Europe face notable exposure because of their dependence on advanced imported computing systems, while Asia-Pacific is experiencing cost pressure associated with infrastructure expansion. Although higher expenses may delay upgrades and increase the cost of large-scale genomic projects, these pressures are also encouraging cloud-based service adoption, regional data center investment, and localized development of bioinformatics platforms and analytical capabilities.
Markets Covered:
1) By Service Type: Structural Annotation; Functional Annotation; Comparative Annotation; Other Service Types
2) By Technology: Next Generation Sequencing; Sanger Sequencing; Other Technologies
3) By Application: Drug Discovery; Personalized Medicine; Agriculture; Biotechnology; Other Applications
4) By End-User: Pharmaceutical and Biotechnology Companies; Academic and Research Institutes; Clinical Laboratories; Other End-Users
Subsegments:
1) By Structural Annotation: Gene Prediction Annotation; Exon Intron Boundary Identification; Regulatory Element Identification; Repeat Sequence Identification; Non Coding Region Annotation
2) By Functional Annotation: Gene Ontology Assignment; Protein Function Characterization; Pathway Mapping Annotation; Protein Domain Identification; Enzyme Activity Annotation
3) By Comparative Annotation: Cross Species Genome Comparison; Ortholog Identification; Paralog Identification; Evolutionary Conservation Analysis; Synteny Mapping Annotation
4) By Other Service Types: Customized Genome Annotation Services; Integrated Multi Omics Annotation; Manual Curation Services; Annotation Quality Validation Services; Database Integration Services
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment